title: Circulating tumor cells and biomarkers: implications for personalized targeted treatments for metastatic breast cancer.
authors.forename: James M
authors.initials: JM
authors.lastname: Reuben
authors.forename: Bang-Ning
authors.initials: BN
authors.lastname: Lee
authors.forename: Changping
authors.initials: C
authors.lastname: Li
authors.forename: Hui
authors.initials: H
authors.lastname: Gao
authors.forename: Kristine R
authors.initials: KR
authors.lastname: Broglio
authors.forename: Vicente
authors.initials: V
authors.lastname: Valero
authors.forename: Summer A
authors.initials: SA
authors.lastname: Jackson
authors.forename: Naoto T
authors.initials: NT
authors.lastname: Ueno
authors.forename: Savitri
authors.initials: S
authors.lastname: Krishnamurthy
authors.forename: Gabriel N
authors.initials: GN
authors.lastname: Hortobagyi
authors.forename: Massimo
authors.initials: M
authors.lastname: Cristofanilli
mesh_terms: D014408:Biomarkers, Tumor; D001943:Breast Neoplasms / Q000737:chemistry / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006801:Humans; D009360:Neoplastic Cells, Circulating; D057285:Precision Medicine; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis; D011960:Receptors, Estrogen / Q000032:analysis; D011980:Receptors, Progesterone / Q000032:analysis
chemical_list: D014408:Biomarkers, Tumor; D018719:Erb-b2 Receptor Tyrosine Kinases; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; C508053:ERBB2 protein, human